ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neuroprotective Products Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-22I7346
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Neuroprotective Products Market Insights and Forecast to 2028
BUY CHAPTERS

Global Neuroprotective Products Market Research Report 2025

Code: QYRE-Auto-22I7346
Report
September 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Genervon
Neurovive Pharmaceutical
Ceregene
BHR Pharma
Neuren Pharmaceuticals
Allon Therapeutics
Bionure
Astrazeneca plc
Biogen
Merck KGaA
Teva Pharmaceutical Industries Ltd
Novartis
GlaxoSmithKline PLC
Pfizer Inc
Sunovion Pharmaceuticals Inc
Hikma Pharmaceuticals PLC
Bioniz Theraputics.

Neuroprotective Products Market Size

The global market for Neuroprotective Products was valued at US$ 24150 million in the year 2024 and is projected to reach a revised size of US$ 27880 million by 2031, growing at a CAGR of 2.1% during the forecast period.

Neuroprotective Products Market

Neuroprotective Products Market

Neuroprotective Products consist of medications that can be used to protect or preserve the neuronal cells of the brain from degeneration, stress, and injury, which can impair cognitive functions. 
Factors expected to drive market growth include increasing prevalence of neurological disorders. Neurological diseases are the leading cause of disability and death worldwide. The “big three” neurodegenerative diseases: Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, have resulted in significant increases in morbidity and mortality in the elderly population worldwide. Neuroprotective drugs are those that help maintain the structure and function of neurons. Neuroprotective drugs have the potential to reduce stroke deaths by 6 million per year. According to data updated by the World Health Organization in February 2022, approximately 50 million people worldwide suffer from epilepsy every year.
Alzheimer"s disease segment is expected to hold major market share in the neuroprotective agents market
The incidence of Alzheimer"s disease has been increasing and is expected to continue to increase in the coming decades. According to statistics from the World Health Organization, nearly 50 million people worldwide were suffering from Alzheimer"s disease and other dementias in 2020, and this number is expected to exceed 152 million by 2050. Additionally, Alzheimer"s disease progression increases with age and is the fifth largest contributor to the global disease burden, with the global disease burden exceeding 1 Trillions of dollars.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neuroprotective Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroprotective Products.
The Neuroprotective Products market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuroprotective Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuroprotective Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Neuroprotective Products Market Report

Report Metric Details
Report Name Neuroprotective Products Market
Accounted market size in year US$ 24150 million
Forecasted market size in 2031 US$ 27880 million
CAGR 2.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Genervon, NeuroVive Pharmaceutical, Ceregene, BHR Pharma, Neuren Pharmaceuticals, Allon therapeutics, Bionure, AstraZeneca, Biogen, Merck KGaA, Teva Pharmaceutical Industries Ltd, Novartis, GlaxoSmithKline plc., Pfizer Inc, Bioniz Theraputics., Sunovion Pharmaceuticals Inc, Hikma Pharmaceuticals PLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Neuroprotective Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Neuroprotective Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Neuroprotective Products Market growing?

Ans: The Neuroprotective Products Market witnessing a CAGR of 2.1% during the forecast period 2025-2031.

What is the Neuroprotective Products Market size in 2031?

Ans: The Neuroprotective Products Market size in 2031 will be US$ 27880 million.

Who are the main players in the Neuroprotective Products Market report?

Ans: The main players in the Neuroprotective Products Market are Genervon, NeuroVive Pharmaceutical, Ceregene, BHR Pharma, Neuren Pharmaceuticals, Allon therapeutics, Bionure, AstraZeneca, Biogen, Merck KGaA, Teva Pharmaceutical Industries Ltd, Novartis, GlaxoSmithKline plc., Pfizer Inc, Bioniz Theraputics., Sunovion Pharmaceuticals Inc, Hikma Pharmaceuticals PLC

What are the Application segmentation covered in the Neuroprotective Products Market report?

Ans: The Applications covered in the Neuroprotective Products Market report are Alzheimer's disease, Multiple sclerosis, Others

What are the Type segmentation covered in the Neuroprotective Products Market report?

Ans: The Types covered in the Neuroprotective Products Market report are Cholinesterase inhibitors, NMDA receptor antagonists, Others

Recommended Reports

Neurological Drugs

Neurology Devices

Neurodegeneration Therapy

1 Neuroprotective Products Market Overview
1.1 Product Definition
1.2 Neuroprotective Products by Type
1.2.1 Global Neuroprotective Products Market Value Comparison by Type (2024 VS 2031)
1.2.2 Cholinesterase inhibitors
1.2.3 NMDA receptor antagonists
1.2.4 Others
1.3 Neuroprotective Products by Application
1.3.1 Global Neuroprotective Products Market Value by Application (2024 VS 2031)
1.3.2 Alzheimer's disease
1.3.3 Multiple sclerosis
1.3.4 Others
1.4 Global Neuroprotective Products Market Size Estimates and Forecasts
1.4.1 Global Neuroprotective Products Revenue 2020-2031
1.4.2 Global Neuroprotective Products Sales 2020-2031
1.4.3 Global Neuroprotective Products Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Neuroprotective Products Market Competition by Manufacturers
2.1 Global Neuroprotective Products Sales Market Share by Manufacturers (2020-2025)
2.2 Global Neuroprotective Products Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Neuroprotective Products Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Neuroprotective Products, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neuroprotective Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neuroprotective Products, Product Type & Application
2.7 Global Key Manufacturers of Neuroprotective Products, Date of Enter into This Industry
2.8 Global Neuroprotective Products Market Competitive Situation and Trends
2.8.1 Global Neuroprotective Products Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Neuroprotective Products Players Market Share by Revenue
2.8.3 Global Neuroprotective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neuroprotective Products Market Scenario by Region
3.1 Global Neuroprotective Products Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Neuroprotective Products Sales by Region: 2020-2031
3.2.1 Global Neuroprotective Products Sales by Region: 2020-2025
3.2.2 Global Neuroprotective Products Sales by Region: 2026-2031
3.3 Global Neuroprotective Products Revenue by Region: 2020-2031
3.3.1 Global Neuroprotective Products Revenue by Region: 2020-2025
3.3.2 Global Neuroprotective Products Revenue by Region: 2026-2031
3.4 North America Neuroprotective Products Market Facts & Figures by Country
3.4.1 North America Neuroprotective Products Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Neuroprotective Products Sales by Country (2020-2031)
3.4.3 North America Neuroprotective Products Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neuroprotective Products Market Facts & Figures by Country
3.5.1 Europe Neuroprotective Products Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Neuroprotective Products Sales by Country (2020-2031)
3.5.3 Europe Neuroprotective Products Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neuroprotective Products Market Facts & Figures by Region
3.6.1 Asia Pacific Neuroprotective Products Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Neuroprotective Products Sales by Region (2020-2031)
3.6.3 Asia Pacific Neuroprotective Products Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neuroprotective Products Market Facts & Figures by Country
3.7.1 Latin America Neuroprotective Products Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Neuroprotective Products Sales by Country (2020-2031)
3.7.3 Latin America Neuroprotective Products Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neuroprotective Products Market Facts & Figures by Country
3.8.1 Middle East and Africa Neuroprotective Products Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Neuroprotective Products Sales by Country (2020-2031)
3.8.3 Middle East and Africa Neuroprotective Products Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Neuroprotective Products Sales by Type (2020-2031)
4.1.1 Global Neuroprotective Products Sales by Type (2020-2025)
4.1.2 Global Neuroprotective Products Sales by Type (2026-2031)
4.1.3 Global Neuroprotective Products Sales Market Share by Type (2020-2031)
4.2 Global Neuroprotective Products Revenue by Type (2020-2031)
4.2.1 Global Neuroprotective Products Revenue by Type (2020-2025)
4.2.2 Global Neuroprotective Products Revenue by Type (2026-2031)
4.2.3 Global Neuroprotective Products Revenue Market Share by Type (2020-2031)
4.3 Global Neuroprotective Products Price by Type (2020-2031)
5 Segment by Application
5.1 Global Neuroprotective Products Sales by Application (2020-2031)
5.1.1 Global Neuroprotective Products Sales by Application (2020-2025)
5.1.2 Global Neuroprotective Products Sales by Application (2026-2031)
5.1.3 Global Neuroprotective Products Sales Market Share by Application (2020-2031)
5.2 Global Neuroprotective Products Revenue by Application (2020-2031)
5.2.1 Global Neuroprotective Products Revenue by Application (2020-2025)
5.2.2 Global Neuroprotective Products Revenue by Application (2026-2031)
5.2.3 Global Neuroprotective Products Revenue Market Share by Application (2020-2031)
5.3 Global Neuroprotective Products Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Genervon
6.1.1 Genervon Company Information
6.1.2 Genervon Description and Business Overview
6.1.3 Genervon Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Genervon Neuroprotective Products Product Portfolio
6.1.5 Genervon Recent Developments/Updates
6.2 NeuroVive Pharmaceutical
6.2.1 NeuroVive Pharmaceutical Company Information
6.2.2 NeuroVive Pharmaceutical Description and Business Overview
6.2.3 NeuroVive Pharmaceutical Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.2.4 NeuroVive Pharmaceutical Neuroprotective Products Product Portfolio
6.2.5 NeuroVive Pharmaceutical Recent Developments/Updates
6.3 Ceregene
6.3.1 Ceregene Company Information
6.3.2 Ceregene Description and Business Overview
6.3.3 Ceregene Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ceregene Neuroprotective Products Product Portfolio
6.3.5 Ceregene Recent Developments/Updates
6.4 BHR Pharma
6.4.1 BHR Pharma Company Information
6.4.2 BHR Pharma Description and Business Overview
6.4.3 BHR Pharma Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BHR Pharma Neuroprotective Products Product Portfolio
6.4.5 BHR Pharma Recent Developments/Updates
6.5 Neuren Pharmaceuticals
6.5.1 Neuren Pharmaceuticals Company Information
6.5.2 Neuren Pharmaceuticals Description and Business Overview
6.5.3 Neuren Pharmaceuticals Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Neuren Pharmaceuticals Neuroprotective Products Product Portfolio
6.5.5 Neuren Pharmaceuticals Recent Developments/Updates
6.6 Allon therapeutics
6.6.1 Allon therapeutics Company Information
6.6.2 Allon therapeutics Description and Business Overview
6.6.3 Allon therapeutics Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Allon therapeutics Neuroprotective Products Product Portfolio
6.6.5 Allon therapeutics Recent Developments/Updates
6.7 Bionure
6.7.1 Bionure Company Information
6.7.2 Bionure Description and Business Overview
6.7.3 Bionure Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bionure Neuroprotective Products Product Portfolio
6.7.5 Bionure Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Company Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AstraZeneca Neuroprotective Products Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Biogen
6.9.1 Biogen Company Information
6.9.2 Biogen Description and Business Overview
6.9.3 Biogen Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Biogen Neuroprotective Products Product Portfolio
6.9.5 Biogen Recent Developments/Updates
6.10 Merck KGaA
6.10.1 Merck KGaA Company Information
6.10.2 Merck KGaA Description and Business Overview
6.10.3 Merck KGaA Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Merck KGaA Neuroprotective Products Product Portfolio
6.10.5 Merck KGaA Recent Developments/Updates
6.11 Teva Pharmaceutical Industries Ltd
6.11.1 Teva Pharmaceutical Industries Ltd Company Information
6.11.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.11.3 Teva Pharmaceutical Industries Ltd Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Teva Pharmaceutical Industries Ltd Neuroprotective Products Product Portfolio
6.11.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.12 Novartis
6.12.1 Novartis Company Information
6.12.2 Novartis Description and Business Overview
6.12.3 Novartis Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Novartis Neuroprotective Products Product Portfolio
6.12.5 Novartis Recent Developments/Updates
6.13 GlaxoSmithKline plc.
6.13.1 GlaxoSmithKline plc. Company Information
6.13.2 GlaxoSmithKline plc. Description and Business Overview
6.13.3 GlaxoSmithKline plc. Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.13.4 GlaxoSmithKline plc. Neuroprotective Products Product Portfolio
6.13.5 GlaxoSmithKline plc. Recent Developments/Updates
6.14 Pfizer Inc
6.14.1 Pfizer Inc Company Information
6.14.2 Pfizer Inc Description and Business Overview
6.14.3 Pfizer Inc Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Pfizer Inc Neuroprotective Products Product Portfolio
6.14.5 Pfizer Inc Recent Developments/Updates
6.15 Bioniz Theraputics.
6.15.1 Bioniz Theraputics. Company Information
6.15.2 Bioniz Theraputics. Description and Business Overview
6.15.3 Bioniz Theraputics. Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Bioniz Theraputics. Neuroprotective Products Product Portfolio
6.15.5 Bioniz Theraputics. Recent Developments/Updates
6.16 Sunovion Pharmaceuticals Inc
6.16.1 Sunovion Pharmaceuticals Inc Company Information
6.16.2 Sunovion Pharmaceuticals Inc Description and Business Overview
6.16.3 Sunovion Pharmaceuticals Inc Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Sunovion Pharmaceuticals Inc Neuroprotective Products Product Portfolio
6.16.5 Sunovion Pharmaceuticals Inc Recent Developments/Updates
6.17 Hikma Pharmaceuticals PLC
6.17.1 Hikma Pharmaceuticals PLC Company Information
6.17.2 Hikma Pharmaceuticals PLC Description and Business Overview
6.17.3 Hikma Pharmaceuticals PLC Neuroprotective Products Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Hikma Pharmaceuticals PLC Neuroprotective Products Product Portfolio
6.17.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neuroprotective Products Industry Chain Analysis
7.2 Neuroprotective Products Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neuroprotective Products Production Mode & Process Analysis
7.4 Neuroprotective Products Sales and Marketing
7.4.1 Neuroprotective Products Sales Channels
7.4.2 Neuroprotective Products Distributors
7.5 Neuroprotective Products Customer Analysis
8 Neuroprotective Products Market Dynamics
8.1 Neuroprotective Products Industry Trends
8.2 Neuroprotective Products Market Drivers
8.3 Neuroprotective Products Market Challenges
8.4 Neuroprotective Products Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Genervon
Neurovive Pharmaceutical
Ceregene
BHR Pharma
Neuren Pharmaceuticals
Allon Therapeutics
Bionure
Astrazeneca plc
Biogen
Merck KGaA
Teva Pharmaceutical Industries Ltd
Novartis
GlaxoSmithKline PLC
Pfizer Inc
Sunovion Pharmaceuticals Inc
Hikma Pharmaceuticals PLC
Bioniz Theraputics.
List of Tables
 Table 1. Global Neuroprotective Products Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Neuroprotective Products Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Neuroprotective Products Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Neuroprotective Products Sales (MT) of Key Manufacturers (2020-2025)
 Table 5. Global Neuroprotective Products Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Neuroprotective Products Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Neuroprotective Products Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Neuroprotective Products Average Price (USD/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Neuroprotective Products, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Neuroprotective Products, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Neuroprotective Products, Product Type & Application
 Table 12. Global Key Manufacturers of Neuroprotective Products, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Neuroprotective Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroprotective Products as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Neuroprotective Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Neuroprotective Products Sales by Region (2020-2025) & (MT)
 Table 18. Global Neuroprotective Products Sales Market Share by Region (2020-2025)
 Table 19. Global Neuroprotective Products Sales by Region (2026-2031) & (MT)
 Table 20. Global Neuroprotective Products Sales Market Share by Region (2026-2031)
 Table 21. Global Neuroprotective Products Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Neuroprotective Products Revenue Market Share by Region (2020-2025)
 Table 23. Global Neuroprotective Products Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Neuroprotective Products Revenue Market Share by Region (2026-2031)
 Table 25. North America Neuroprotective Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Neuroprotective Products Sales by Country (2020-2025) & (MT)
 Table 27. North America Neuroprotective Products Sales by Country (2026-2031) & (MT)
 Table 28. North America Neuroprotective Products Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Neuroprotective Products Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Neuroprotective Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Neuroprotective Products Sales by Country (2020-2025) & (MT)
 Table 32. Europe Neuroprotective Products Sales by Country (2026-2031) & (MT)
 Table 33. Europe Neuroprotective Products Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Neuroprotective Products Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Neuroprotective Products Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Neuroprotective Products Sales by Region (2020-2025) & (MT)
 Table 37. Asia Pacific Neuroprotective Products Sales by Region (2026-2031) & (MT)
 Table 38. Asia Pacific Neuroprotective Products Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Neuroprotective Products Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Neuroprotective Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Neuroprotective Products Sales by Country (2020-2025) & (MT)
 Table 42. Latin America Neuroprotective Products Sales by Country (2026-2031) & (MT)
 Table 43. Latin America Neuroprotective Products Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Neuroprotective Products Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Neuroprotective Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Neuroprotective Products Sales by Country (2020-2025) & (MT)
 Table 47. Middle East and Africa Neuroprotective Products Sales by Country (2026-2031) & (MT)
 Table 48. Middle East and Africa Neuroprotective Products Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Neuroprotective Products Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Neuroprotective Products Sales (MT) by Type (2020-2025)
 Table 51. Global Neuroprotective Products Sales (MT) by Type (2026-2031)
 Table 52. Global Neuroprotective Products Sales Market Share by Type (2020-2025)
 Table 53. Global Neuroprotective Products Sales Market Share by Type (2026-2031)
 Table 54. Global Neuroprotective Products Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Neuroprotective Products Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Neuroprotective Products Revenue Market Share by Type (2020-2025)
 Table 57. Global Neuroprotective Products Revenue Market Share by Type (2026-2031)
 Table 58. Global Neuroprotective Products Price (USD/Kg) by Type (2020-2025)
 Table 59. Global Neuroprotective Products Price (USD/Kg) by Type (2026-2031)
 Table 60. Global Neuroprotective Products Sales (MT) by Application (2020-2025)
 Table 61. Global Neuroprotective Products Sales (MT) by Application (2026-2031)
 Table 62. Global Neuroprotective Products Sales Market Share by Application (2020-2025)
 Table 63. Global Neuroprotective Products Sales Market Share by Application (2026-2031)
 Table 64. Global Neuroprotective Products Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Neuroprotective Products Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Neuroprotective Products Revenue Market Share by Application (2020-2025)
 Table 67. Global Neuroprotective Products Revenue Market Share by Application (2026-2031)
 Table 68. Global Neuroprotective Products Price (USD/Kg) by Application (2020-2025)
 Table 69. Global Neuroprotective Products Price (USD/Kg) by Application (2026-2031)
 Table 70. Genervon Company Information
 Table 71. Genervon Description and Business Overview
 Table 72. Genervon Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 73. Genervon Neuroprotective Products Product
 Table 74. Genervon Recent Developments/Updates
 Table 75. NeuroVive Pharmaceutical Company Information
 Table 76. NeuroVive Pharmaceutical Description and Business Overview
 Table 77. NeuroVive Pharmaceutical Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 78. NeuroVive Pharmaceutical Neuroprotective Products Product
 Table 79. NeuroVive Pharmaceutical Recent Developments/Updates
 Table 80. Ceregene Company Information
 Table 81. Ceregene Description and Business Overview
 Table 82. Ceregene Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 83. Ceregene Neuroprotective Products Product
 Table 84. Ceregene Recent Developments/Updates
 Table 85. BHR Pharma Company Information
 Table 86. BHR Pharma Description and Business Overview
 Table 87. BHR Pharma Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 88. BHR Pharma Neuroprotective Products Product
 Table 89. BHR Pharma Recent Developments/Updates
 Table 90. Neuren Pharmaceuticals Company Information
 Table 91. Neuren Pharmaceuticals Description and Business Overview
 Table 92. Neuren Pharmaceuticals Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 93. Neuren Pharmaceuticals Neuroprotective Products Product
 Table 94. Neuren Pharmaceuticals Recent Developments/Updates
 Table 95. Allon therapeutics Company Information
 Table 96. Allon therapeutics Description and Business Overview
 Table 97. Allon therapeutics Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 98. Allon therapeutics Neuroprotective Products Product
 Table 99. Allon therapeutics Recent Developments/Updates
 Table 100. Bionure Company Information
 Table 101. Bionure Description and Business Overview
 Table 102. Bionure Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 103. Bionure Neuroprotective Products Product
 Table 104. Bionure Recent Developments/Updates
 Table 105. AstraZeneca Company Information
 Table 106. AstraZeneca Description and Business Overview
 Table 107. AstraZeneca Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 108. AstraZeneca Neuroprotective Products Product
 Table 109. AstraZeneca Recent Developments/Updates
 Table 110. Biogen Company Information
 Table 111. Biogen Description and Business Overview
 Table 112. Biogen Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 113. Biogen Neuroprotective Products Product
 Table 114. Biogen Recent Developments/Updates
 Table 115. Merck KGaA Company Information
 Table 116. Merck KGaA Description and Business Overview
 Table 117. Merck KGaA Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 118. Merck KGaA Neuroprotective Products Product
 Table 119. Merck KGaA Recent Developments/Updates
 Table 120. Teva Pharmaceutical Industries Ltd Company Information
 Table 121. Teva Pharmaceutical Industries Ltd Description and Business Overview
 Table 122. Teva Pharmaceutical Industries Ltd Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 123. Teva Pharmaceutical Industries Ltd Neuroprotective Products Product
 Table 124. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
 Table 125. Novartis Company Information
 Table 126. Novartis Description and Business Overview
 Table 127. Novartis Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 128. Novartis Neuroprotective Products Product
 Table 129. Novartis Recent Developments/Updates
 Table 130. GlaxoSmithKline plc. Company Information
 Table 131. GlaxoSmithKline plc. Description and Business Overview
 Table 132. GlaxoSmithKline plc. Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 133. GlaxoSmithKline plc. Neuroprotective Products Product
 Table 134. GlaxoSmithKline plc. Recent Developments/Updates
 Table 135. Pfizer Inc Company Information
 Table 136. Pfizer Inc Description and Business Overview
 Table 137. Pfizer Inc Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 138. Pfizer Inc Neuroprotective Products Product
 Table 139. Pfizer Inc Recent Developments/Updates
 Table 140. Bioniz Theraputics. Company Information
 Table 141. Bioniz Theraputics. Description and Business Overview
 Table 142. Bioniz Theraputics. Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 143. Bioniz Theraputics. Neuroprotective Products Product
 Table 144. Bioniz Theraputics. Recent Developments/Updates
 Table 145. Sunovion Pharmaceuticals Inc Company Information
 Table 146. Sunovion Pharmaceuticals Inc Description and Business Overview
 Table 147. Sunovion Pharmaceuticals Inc Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 148. Sunovion Pharmaceuticals Inc Neuroprotective Products Product
 Table 149. Sunovion Pharmaceuticals Inc Recent Developments/Updates
 Table 150. Hikma Pharmaceuticals PLC Company Information
 Table 151. Hikma Pharmaceuticals PLC Description and Business Overview
 Table 152. Hikma Pharmaceuticals PLC Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 153. Hikma Pharmaceuticals PLC Neuroprotective Products Product
 Table 154. Hikma Pharmaceuticals PLC Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Neuroprotective Products Distributors List
 Table 158. Neuroprotective Products Customers List
 Table 159. Neuroprotective Products Market Trends
 Table 160. Neuroprotective Products Market Drivers
 Table 161. Neuroprotective Products Market Challenges
 Table 162. Neuroprotective Products Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Neuroprotective Products
 Figure 2. Global Neuroprotective Products Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Neuroprotective Products Market Share by Type: 2024 & 2031
 Figure 4. Cholinesterase inhibitors Product Picture
 Figure 5. NMDA receptor antagonists Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Neuroprotective Products Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Neuroprotective Products Market Share by Application: 2024 & 2031
 Figure 9. Alzheimer's disease
 Figure 10. Multiple sclerosis
 Figure 11. Others
 Figure 12. Global Neuroprotective Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Neuroprotective Products Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Neuroprotective Products Sales (2020-2031) & (MT)
 Figure 15. Global Neuroprotective Products Average Price (USD/Kg) & (2020-2031)
 Figure 16. Neuroprotective Products Report Years Considered
 Figure 17. Neuroprotective Products Sales Share by Manufacturers in 2024
 Figure 18. Global Neuroprotective Products Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Neuroprotective Products Players: Market Share by Revenue in Neuroprotective Products in 2024
 Figure 20. Neuroprotective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Neuroprotective Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Neuroprotective Products Sales Market Share by Country (2020-2031)
 Figure 23. North America Neuroprotective Products Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Neuroprotective Products Sales Market Share by Country (2020-2031)
 Figure 27. Europe Neuroprotective Products Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Neuroprotective Products Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Neuroprotective Products Revenue Market Share by Region (2020-2031)
 Figure 35. China Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Neuroprotective Products Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Neuroprotective Products Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Neuroprotective Products Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Neuroprotective Products Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Neuroprotective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Neuroprotective Products by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Neuroprotective Products by Type (2020-2031)
 Figure 57. Global Neuroprotective Products Price (USD/Kg) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Neuroprotective Products by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Neuroprotective Products by Application (2020-2031)
 Figure 60. Global Neuroprotective Products Price (USD/Kg) by Application (2020-2031)
 Figure 61. Neuroprotective Products Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Neuroprotective Drugs Market Research Report 2024
Neuroprotection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neuroprotective Agents Market Insights Forecast to 2030
Brain Health Supplements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nervous System Chemicals Market Research Report 2024
Global Nootropics Brain Supplements Market Insights Forecast to 2030
Global Neurodegenerative Disorder Therapeutics Market Research Report 2024
Dementia and Alzheimer s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rare Neurodegenerative Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neurodegenerative Disease Treatment Market Research Report 2024
Neuroscience Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Memory Enhancing Drug Market Insights Forecast to 2030
Global Nootropic Supplements Market Insights Forecast to 2030
Nerve Repair and Re generation Biologic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neuroscience Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Neuroscience Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Aging Products and Therapies Market Insights Forecast to 2030
Neurorehabilitation Devices Market
Brain Protection Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neurorehabilitation Therapy Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions